EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

T Cell Peptide Prediction, Immune Response, and Host–Pathogen Relationship in Vaccinated and Recovered from Mild COVID-19 Subjects

Iole Macchia iD, Valentina La Sorsa, Alessandra Ciervo iD, Irene Ruspantini, Donatella Negri iD, Martina Borghi, Maria Laura De Angelis iD, Francesca Luciani iD, Antonio Martina, Silvia Taglieri iD, Valentina Durastanti, Maria Concetta Altavista und 2 weitere

Biomolecules · 2024

DOI: 10.3390/biom14101217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Iole Macchia und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, COVID-19 Vaccines, Host-Pathogen Interactions. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Istituto Superiore di Sanità.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

COVID-19 remains a significant threat, particularly to vulnerable populations. The emergence of new variants necessitates the development of treatments and vaccines that induce both humoral and cellular immunity. This study aimed to identify potentially immunogenic SARS-CoV-2 peptides and to explore the intricate host–pathogen interactions involving peripheral immune responses, memory profiles, and various demographic, clinical, and lifestyle factors. Using in silico and experimental methods, we identified several CD8-restricted SARS-CoV-2 peptides that are either poorly studied or have previously unreported immunogenicity: fifteen from the Spike and three each from non-structural proteins Nsp1-2-3-16. A Spike peptide, LA-9, demonstrated a 57% response rate in ELISpot assays using PBMCs from 14 HLA-A*02:01 positive, vaccinated, and mild-COVID-19 recovered subjects, indicating its potential for diagnostics, research, and multi-epitope vaccine platforms. We also found that younger individuals, with fewer vaccine doses and longer intervals since infection, showed lower anti-Spike (ELISA) and anti-Wuhan neutralizing antibodies (pseudovirus assay), higher naïve T cells, and lower central memory, effector memory, and CD4hiCD8low T cells (flow cytometry) compared to older subjects. In our cohort, a higher prevalence of Vδ2-γδ and DN T cells, and fewer naïve CD8 T cells, seemed to correlate with strong cellular and lower anti-NP antibody responses and to associate with Omicron infection, absence of confusional state, and habitual sporting activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2COVID-19 VaccinesHost-Pathogen InteractionsHumansMaleFemaleAdultMiddle AgedSpike Glycoprotein, CoronavirusCD8-Positive T-LymphocytesVaccinationPeptidesAntibodies, ViralAntibodies, NeutralizingAgedEpitopes, T-Lymphocyte

Stichwörter der Autor:innen

COVID-19ELISpotT cell epitopesT peptidebioinformaticsneutralizing antibodies

Substanzen

COVID-19 VaccinesSpike Glycoprotein, CoronavirusPeptidesspike protein, SARS-CoV-2Antibodies, ViralAntibodies, NeutralizingEpitopes, T-Lymphocyte

Autor:innen und Institutionen

  • Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy.
  • Research Promotion and Coordination Service, Istituto Superiore di Sanità, 00161 Rome, Italy.
  • Department of Infectious Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy.
  • Core Facilities, Istituto Superiore di Sanità, 00161 Rome, Italy.
  • National Center for the Control and Evaluation of Medicines, Istituto Superiore di Sanità, 00161 Rome, Italy.
  • Neurology Unit, San Filippo Neri Hospital, ASL RM1, 00135 Rome, Italy.

ORCID-Profile: Iole Macchia, Alessandra Ciervo, Donatella Negri, Maria Laura De Angelis, Francesca Luciani, Silvia Taglieri, Francesca Urbani

Förderung

  • Istituto Superiore di Sanità

Zitieren

APA

Macchia, I., La Sorsa, V., Ciervo, A., Ruspantini, I., Negri, D., Borghi, M., De Angelis, M. L., Luciani, F., Martina, A., Taglieri, S., Durastanti, V., Altavista, M. C., Urbani, F., & Mancini, F. (2024). T Cell Peptide Prediction, Immune Response, and Host–Pathogen Relationship in Vaccinated and Recovered from Mild COVID-19 Subjects. Biomolecules. https://doi.org/10.3390/biom14101217

Vancouver

Macchia I, La Sorsa V, Ciervo A, Ruspantini I, Negri D, Borghi M, et al. T Cell Peptide Prediction, Immune Response, and Host–Pathogen Relationship in Vaccinated and Recovered from Mild COVID-19 Subjects. Biomolecules. 2024. doi:10.3390/biom14101217

BibTeX
@article{Macchia2024,
  author = {Macchia, Iole and La Sorsa, Valentina and Ciervo, Alessandra and Ruspantini, Irene and Negri, Donatella and Borghi, Martina and De Angelis, Maria Laura and Luciani, Francesca and Martina, Antonio and Taglieri, Silvia and Durastanti, Valentina and Altavista, Maria Concetta and Urbani, Francesca and Mancini, Fabiola},
  title = {T Cell Peptide Prediction, Immune Response, and Host–Pathogen Relationship in Vaccinated and Recovered from Mild COVID-19 Subjects},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14101217}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche